Patients across Iran are facing severe difficulties obtaining essential medicines due to shortages and rising prices, according to the state news agency IRNA. The report said shortages have affected drugs such as Clidinium-C, certain antibiotics, Ascentra, and Estradiol Valerate. Health officials, however, continue to deny claims of a major crisis in the pharmaceutical market.
IRNA reported that a three-sheet pack of 2 mg Estradiol Valerate, used in infertility and other treatments, officially costs about 840,000 rials, or roughly 47 cents, but is being sold on the black market for between 5 million and 17 million rials, equivalent to $2.80 to $9.40. A woman undergoing IVF treatment in Tehran said she searched pharmacies for over seven hours to find only three sheets of the drug, criticizing the government for promoting childbirth while basic IVF medicines remain scarce.
The report attributed the disruptions in production and pricing to foreign exchange fluctuations, international sanctions, raw material import issues, energy costs, liquidity shortages, and funding gaps in the insurance sector. Some drug prices were raised before insurance systems updated their rates, forcing patients to pay more out of pocket.
আমার দেশ অনলাইন প্রকাশ : ১৬ মে ২০২৬, ১২: ৩৮আপডেট : ১৬ মে ২০২৬, ১২: ৪৪ ইরানে ওষুধের সংকট ও মূল্যবৃদ্ধির কারণে বহু রোগী প্রয়োজনীয় ওষুধ সংগ্রহে চরম ভোগান্তিতে পড়ছেন। রাষ্ট্রীয় বার্তা সংস্থা ইরনা উৎপাদন ও সরবরাহ কেন্দ্রগুলোতে অনুসন্ধানের ভিত্তিতে এ তথ্য
The ‘1 Nojor’ media platform is now live in beta, inviting users to explore and provide feedback as we continue to refine the experience.
